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Objective. To determine the diagnostic value of transvaginal ultrasonography and hystero-
scopy in patients with postmenopausal bleeding.
Material and methods. Between January 1, 1998 and June 30, 1999, 88 outpatient women with
postmenopausal bleeding were enrolled in a prospective study. They underwent transvaginal
ultrasonography and hysteroscopy, and were submitted to directed biopsy during hystero-
scopy. Findings were classified as normal endometrium, suggestive of atrophy, focal abnor-
mality (benign or suspicious), and diffuse thickness (benign or suspicious). Data was com-
pared with the final diagnosis, established by histological examination, as atrophy, benign
pathology, atypical hyperplasia and endometrial carcinoma.
Results. Among 88 women enrolled, 15 were excluded because hysteroscopy was impossible,
and four had abandoned the study. The histological findings were scanty material in 12
(17.4%), atrophy in 24 (34.8%), cystic atrophy in one (1.4%), normal endometrium in five
(7.2%), tuberculous endometritis in one (1.4%), polyps in 12 (17.4%), leiomyoma in one
(1.4%), non-atypical hyperplasia in three (4.3%), atypical hyperplasia in one (1.4%) and endo-
metrial carcinoma in nine cases (13.0%). For the assessment of endometrial carcinoma, ultra-
sonography revealed sensitivity 77.8%, specificity 93.3%, positive predictive value 63.6%, nega-
tive predictive value 96.6%; and hysteroscopy revealed sensitivity of 88.9%, specificity 98.3%,
positive predictive value 88.9%, negative predictive value 98.3%. The combined use of both
methods revealed sensitivity 100%, specificity 91.7%, positive predictive value 64.3%, negative
predictive value 100%.
Conclusions. Both imagiological methods were found to be useful screening tests for endomet-
rial carcinoma. Hysteroscopy was a superior diagnostic procedure.
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Postmenopausal bleeding is a common gynecolog-
ic complaint, accounting for up to 69% of post-
menopausal women referred to gynecological out-
patient clinics (1). Approximately 90% of women
with endometrial carcinoma report vaginal
bleeding as their only complaint (2, 4), so this
Abbreviations:
D&C: dilatation and curettage; HRT: hormone replacement
therapy; IU: international unit.
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symptom should always be carefully investigated.
However, just 10–15% of women with post-
menopausal bleeding have endometrial carcinoma
(2, 3, 5–8).
Dilatation and curettage (D&C) is still con-
sidered the ‘gold standard’ for the investigation of
postmenopausal bleeding (9), although it is an in-
vasive procedure, requiring inpatient admission
and general anesthesia, associated with some mor-
bidity and even mortality (5, 9). As a blind pro-
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cedure, it often results in unrepresentative biopsies
(8) with a diagnostic failure that varies from 10 to
25% (10), and false negative rates between 2 and
10% (1, 5, 9, 11). Prior reports have revealed that
in 60% of women submitted to curettage less than
half of the uterine cavity was sampled with the cu-
rette and that the source of bleeding was frequently
not diagnosed (12, 13).
Diagnostic hysteroscopy allows direct visualiza-
tion and biopsy of diffuse or focal abnormalities
of the endometrium. It is a well-tolerated, accu-
rate, and sensitive outpatient procedure, and a high
predictive value in the investigation of post-
menopausal bleeding has been well documented (1,
6, 8, 10, 11, 13, 14). It is, however, a rather invasive
method and carries a false negative rate of 3% (11).
Transvaginal ultrasonography with high-resol-
ution transducers allows a good definition of the
endometrial-myometrial interface and visualiza-
tion of the entire endometrial cavity. Several
studies have assessed the accuracy of transvaginal
ultrasonography in evaluating the endometrium
for malignancy (8, 11, 15–18). Different cut-off
levels for endometrial thickness have been used, re-
sulting in varying degrees of reliability for de-
tecting endometrial disease (1, 3, 6, 8, 9, 11, 17,
18). Transvaginal ultrasonography is a highly sen-
sitive test for detecting endometrial disease, but
carries a false negative rate of 8% for endometrial
carcinoma (15). Recent reports showed that the
combined assessment of endometrial thickness
with some morphologic parameters improve the
diagnostic accuracy of transvaginal sonography in
patients with postmenopausal bleeding (5).
The purpose of our study was to determine the
diagnostic accuracy of transvaginal ultrasono-
graphy and hysteroscopy in women with post-
menopausal bleeding.
Material and methods
Between January 1, 1998 and June 30, 1999, 88
women with postmenopausal bleeding were en-
rolled in a prospective study at the Department of
Gynecology of University Hospital of Coimbra.
These patients were consecutively recruited from
gynecologic outpatient clinics, emergency depart-
ments or directly from general practice for investi-
gation of postmenopausal bleeding, according to a
previously defined protocol. The patients first
underwent a standard outpatient evaluation. Re-
productive history and a complete medical and
surgical history, giving special attention to hyper-
tension, diabetes, obesity, use of hormone replace-
ment therapy (HRT), anti-estrogen therapy, antico-
agulants or other therapies were recorded. Meno-
pause was defined as spontaneous cessation of
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menses for more than one year or serum follicle-
stimulating hormone levels .30 mIU/ml. A gen-
eral physical examination and a careful gynecolog-
ic examination, including cervical smear were per-
formed. Data was collected in a standard format
for all patients. Each patient gave informed con-
sent to participate in the study.
Ultrasonography was performed with the use of
an Aloka SSD 2000 MultiView with a 5MHz
transvaginal transducer by one of the authors
(L.A.S.). Endometrial thickness was measured as a
double layer in the longitudinal plane at the widest
point within the fundus and with the entire endo-
cervical and endometrial stripe visible. Uterine
contour was evaluated and the presence of intra-
mural or submucosal lesions, as well as adnexial
pathology were recorded. The ultrasonographic
criteria considered to define a normal endo-
metrium were normal endometrial thickness (Æ4
mm without HRT and Æ 8 mm with HRT) and
endometrial regularity. Endometrial ultrasono-
graphic findings were classified as normal endo-
metrium, suggestive of atrophy, focal abnormality
(benign or suspicious) and diffuse thickness (be-
nign or suspicious).
Hysteroscopy was performed with a 4 mm Storz
II rigid hysteroscope and the uterine cavity was
distended with a low-flow, high-pressure carbon
dioxide insuflation system, without paracervical
block nor cervical dilatation before the procedure.
It was performed immediately after ultrasono-
graphy by either one of two authors (F.F., I.D.)
who were not aware of the sonographic results.
The images were viewed on a high-resolution color
monitor. The hysteroscope was guided through the
endocervical canal into the uterine cavity under
visual control. The cavity and endometrial surface
were inspected systematically, and the tubal ostia
identified by rotation of the hysteroscope. Hystero-
scopic findings were classified as normal endo-
metrium, suggestive of atrophy, focal abnormality
(benign or suspicious) and diffuse thickness (be-
nign or suspicious).
Endometrial biopsy was performed at the end
of hysteroscopy with a Novak curette or by an di-
rected biopsy. Histologic diagnosis was given by an
associate investigator (T.S.) who was blinded to the
ultrasonographic and hysteroscopic findings, as
atrophy, benign pathology (polyp, submucous lei-
omyoma or non-atypical hyperplasia), atypical hy-
perplasia, and endometrial carcinoma. Patients
whose collected specimens were classified as scanty
material were included in the simple atrophy
group.
After completing the protocol examinations,
women were re-evaluated in an outpatient clinic,
where data was analyzed, and were submitted to
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Table I. Characteristics of the study group
Patients
(nΩ69)
Age (years) *62.1∫8.9 (43–82)
Years after menopause (years) *12.7∫9.6 (1–38)
HRT 13 (18.8%)
Hypertension 25 (36.2%)
Diabetes mellitus 8 (11.6%)
Anticoagulant therapy 6 (8.7%)
Other therapies 6 (8.7%)
* mean∫s.d.
medical or surgical therapy if necessary. Histologic
diagnoses were compared to the ultrasonographic
and hysteroscopic findings, and the sensitivity,
specificity positive predictive value, and negative
predictive value were calculated.
All procedures followed the ethical guidelines ap-
proved by the authorities of our University Hos-
pital.
Results
Among 88 women enrolled in the study, just 69 had
completed the protocol: 15 (17%) were excluded be-
cause of impracticable hysteroscopy due to cervical
stenosis and the remaining four (4.5%) patients
abandoned the study. The mean age of women par-
ticipating in the study was 62.1∫8.9 years, ranging
from 43 to 82 years, and they were postmenopausal
for an average of 12.7∫9.6 years, ranging from 1 to
38 years. Just 13 women (18.8%) had ever had hor-
mone replacement therapy. The characteristics of
the study group are listed in Table I.
Transvaginal ultrasonography was performed in
all women. Ultrasonographic findings were (Fig. 1)
Table II. Incidence of normal and pathological endometrial results in relation to endometrial thickness
Histologic diagnosis
(nΩ69)
Normal endometrium/Atrophy Benign pathology Suspicious pathology Endometrial carcinoma
Endometrial thickness (mm) nΩ25 nΩ34 nΩ1 nΩ9
Æ4 16 7 – –
(nΩ23) (23.2%) (10.1%)
4.1–8 9 9 – –
(nΩ18) (13.0%) (13.0%)
8.1–12 – 7 – 1
(nΩ8) (10.1%) (1.4%)
12.1–16 – 4 – 4
(nΩ8) (5.8%) (5.8%)
16.1–20 – 1 1 –
(nΩ2) (1.4%) (1.4%)
.20 – 6 – 4
(nΩ10) (8.7%) (5.8%)
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Fig. 1. Ultrasonographic findings.
normal endometrium in six (8.7%), suggestive of
atrophy in 25 (36.2%), benign focal abnormality in
13 (18.8%), suspicious focal abnormality in three
(4.3%), benign diffuse thickness in 13 (18.8%), sus-
picious diffuse thickness in eight (11.6%), and in-
tracavitary fluid in one (1.4%). Ten women (14.5%)
presented associated myometrial pathology (fi-
broids), and three patients (4.3%), presented as-
sociated adnexial pathology (two simple ovarian
cysts and one ovarian carcinoma). Mean endomet-
rial thickness was 10.3∫10.9 mm (min. 0, max. 45
mm), being Æ4 mm in 23 (33.3%) cases, 4.1–8 mm
in 18 (26.1%), 8.1–12 mm in eight (11.6%), 12.1–
16 mm in eight (11.6%), 16.1–20 mm in two (2.9%)
and .20 mm in ten (14.5%). Table II shows the
incidence of normal and pathological endometrial
results in relation to endometrial thickness.
Hysteroscopy was impossible to perform in 15
women who were excluded from the protocol. Hys-
teroscopic findings were (Fig. 2) normal endo-
metrium in two (2.9%), suggestive of atrophy in 22
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Fig. 2. Hysteroscopic findings.
(31.9%), benign focal abnormality in 34 (49.3%),
suspicious focal abnormality in seven (10.1%), be-
nign diffuse thickness in one (1.4%) and suspicious
diffuse thickness in two (2.9%). Purulent endo-
metritis was found in one case (1.4%).
The correlation between ultrasonographic and
hysteroscopic findings are shown in Table III. The
main differences concerned the discrimination be-
tween diffuse and focal abnormalities. Ten cases
classified as benign diffuse thickness at ultrasono-
graphy were found to be benign focal abnormali-
ties at hysteroscopy.
Endometrial sampling was performed by di-
rected biopsy in 14 (20.3%) women and by Novak
curettage in the others. Endometrial pathology
was revealed in 27 women (39.1%). Histologic
findings consisted of (Fig. 3) scanty material in 12
(17.4%) cases, normal endometrium in five (7.2%),
atrophy in 24 (34.8%) cases, cystic atrophy in one
(1.4%) case, tuberculous endometritis in one
(1.4%), polyps in 12 (17.4%) cases, leiomyoma in
one (1.4%) case, non-atypical hyperplasia in three
(4.3%) cases, atypical hyperplasia in one (1.4%)
case and endometrial carcinoma in nine cases
(13.0%).




Suggestive Normal Benign focal diffuse focal Suspicious Other
atrophy endometrium abnormality thickness abnorm. diffuse thickness conditions
Suggestive atrophy 19 2 1 – – – –
Normal endometrium 1 – – 1 – – –
Benign focal abnormality 5 4 11 10 2 2 –
Benign diffuse thickness – – – – – 3 –
Suspicious focal abnorm. – – 1 2 1 2 –











Other conditions – – – – – – 1*
* Purulent (tuberculous) endometritis.
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Fig. 3. Pathologic findings.
Thirty-nine women had surgical therapy: 22
women were submitted to operative hysteroscopy
with resection of 21 polyps and 1 leiomyoma, and
17 women were submitted to laparotomy with total
hysterectomy and bilateral adnexectomy (eight for
endometrial carcinoma, one for atypical hyper-
plasia, four for benign pathology and two for as-
sociated adnexial pathology). The final diagnosis
established by histology and the comparison of
this diagnosis with biopsies is listed in Table IV.
The discrepancy between biopsy results and oper-
ative histologic results mainly concerned focal
endometrial abnormalities (in nine polyps and one
leiomyoma the biopsy result was atrophy/scanty
material).
Table V shows the relationship between ultra-
sonographic and hysteroscopic findings and histo-
logic results obtained either by biopsy or surgical
procedure.
There were 13 (18.8%) women who were submit-
ted to hormone replacement therapy (HRT), using
a combined estrogen-progestin regimen. Their
mean age was 55.5∫5.6 years (min. 50, max. 70
years) and were postmenopausal for 6.7∫4.8 years
(min. 1, max. 18 years). In this group of patients,
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Table IV. Endometrial biopsy results versus final histologic diagnosis in women submitted to operative hysteroscopy or hysterectomy at the end of the study
Endometrial biopsy results
(nΩ39)
Atrophy Normal Non-atypical Atypical Endometrial Other
/scanty material endometrium Polyp Leiomyoma hyperplasia hyperplasia carcinoma conditions
Atrophy/scanty material
Normal endometrium






















Other conditions 3 2
Table V. Relationship between ultrasonographic and hysteroscopic findings and histologic results obtained either by biopsy or surgical procedure
Histologic diagnosis
(nΩ69)
Atrophy Normal Non-atypical Atypical Endometrial Other
/scanty material endometrium Polyp Leiomyoma hyperplasia hyperplasia carcinoma conditions
Suggestive atrophy 19 1 3 2
Normal endometrium 1 1 2 2*
Benign focal abnormality 1 10 1 1
Benign diffuse thickness 2 7 1 1 1 1*
Suspicious focal abnorm. 2 1








Suggestive atrophy 19 2 1
Normal endometrium 1 1
Benign focal abnormality 1 1 24 3 1 1 3*
Benign diffuse thickness 1*
Suspicious focal abnorm. 1 6








‡ tuberculous endometritis; * cystic atrophy.
the mean endometrial thickness measured by
transvaginal ultrasonography was 5.7∫3.1 mm
(ranging from 1 to 11 mm), and the ultrasono-
graphic findings were normal endometrium in
three, suggestive of atrophy in six, benign focal ab-
normality in two, and benign diffuse thickness in
two patients. Hysteroscopy revealed normal endo-
metrium in one, endometrium suggestive of atro-
phy in seven, and benign focal abnormality in five
patients. In nine patients endometrial pathology
was not observed (atrophy in seven, normal endo-
metrium in two), and the remaining four patients
presented benign endometrial pathology (polyps in
three and non-atypical hyperplasia in one).
Endometrial carcinoma was detected in nine
(13.0%) women. Their mean age was 69.4∫10.8
years, ranging from 52 to 82 years and they were
postmenopausal for 20.2∫13.0 years, ranging
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from one to 38 years. Among this group none of
the patients used HRT; five patients suffered from
hypertension and two patients were diabetic. The
mean endometrial thickness measured by transva-
ginal ultrasonography was 21.4∫9.5 mm (min. 10
mm, max. 38 mm). Ultrasonographic findings were
suspicious diffuse thickness in six, suspicious focal
abnormality in one, benign focal abnormality in
one, and benign diffuse thickness in one patient.
Hysteroscopic findings were suspicious diffuse
thickness in two, suspicious focal abnormality in
six, and benign focal abnormality in one patient.
For assessment of endometrial carcinoma, trans-
vaginal ultrasonography revealed sensitivity
77.8%, specificity 93.3%, positive predictive value
63.6%, negative predictive value 96.6%; hystero-
scopy revealed sensitivity 88.9%, specificity 98.3%,
positive predictive value 88.9%, negative predictive
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value 98.3%. Ultrasonography, with evaluation of
endometrial thickness alone, using a cut-of value
of 4 mm, showed a sensitivity, specificity, positive
predictive value and negative predictive value for
detecting endometrial carcinoma of 100%, 46%,
19.6% and 100%, respectively. The combined use
of ultrasonography and hysteroscopy revealed sen-
sitivity 100%, specificity 91.7%, positive predictive
value 64.3%, negative predictive value 100%.
For the assessment of endometrial pathology as
a whole, ultrasonography revealed sensitivity
79.5%, specificity 88%, positive predictive value
92.1%, negative predictive value 71%; and hystero-
scopy revealed sensitivity 97.7%, specificity 92%,
positive predictive value 95.5%, negative predictive
value 95.8%. The combined use of ultrasono-
graphy and hysteroscopy revealed sensitivity
97.7%, specificity 84.0%, positive predictive value
91.5%, negative predictive value 95.5%.
Discussion
Postmenopausal bleeding is the presenting com-
plaint in approximately 90% of patients with endo-
metrial carcinoma (2). However, endometrial carci-
noma contributes to 10–15% of postmenopausal
bleeding and the majority of patients with this
bleeding have no detectable organic cause (4, 17).
Dilatation and curettage (D&C) still remains the
usual diagnostic procedure for these patients, de-
spite inherent diagnostic limitations and the fact
that it is an invasive inpatient procedure (5, 9).
Furthermore, focal benign abnormalities are
usually missed by this procedure and may be a
source of continued or recurrent bleeding (2).
In the present study we have detected endomet-
rial pathology in 63.8% of women with post-
menopausal bleeding, which is slightly superior to
previous reports (2, 14, 15). Moreover, in our
study, endometrial carcinoma had a prevalence of
13%. Furthermore, combining transvaginal ultra-
sonography and hysteroscopy, which represented
our methodology, not a single endometrial carci-
noma was missed.
Transvaginal ultrasonography was performed in
all patients and was well tolerated. Findings were
classified according to endometrial thickness and,
using morphological criteria, in six classes (normal
endometrium, suggestive of atrophy, benign focal
abnormality, suspicious focal abnormality, benign
diffuse thickness and suspicious diffuse thickness).
According to this classification, ultrasonography
revealed a sensitivity, specificity, positive predictive
value and negative predictive value of 79.5%, 88%,
92.1% and 71%, respectively, referring to endomet-
rial pathology. Comparing these results with pre-
vious reports, we found a lower sensitivity (79.5%
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vs. 97% as obtained by Weber et al. (5), who com-
bined endometrial morphology, endometrial bor-
der and endometrial thickness, and used a cut-off
value of 5 mm), nevertheless a higher specificity
(88% vs. 65%) (5) was observed in our study. The
low sensitivity of transvaginal ultrasonography ob-
served in our study resulted from the fact that this
technique missed seven cases of benign pathology
with endometrial thickness inferior to 4 mm (five
endometrial polyps measuring less than 3 mm and
two small submucous leiomyomas covered by thin
endometrium).
Considering endometrial carcinoma, transva-
ginal ultrasonography parameters revealed values
of sensitivity 77.8%, specificity 93.3%, positive
predictive value 63.6%, and negative predictive
value 96.6%. If endometrial thickness was the
only parameter considered, using a cut-off value
of 4 mm for malignant pathology, ultrasono-
graphy revealed a sensitivity of 100% and nega-
tive predictive value of 100%, but a specificity of
46% and positive predictive value of 19.6%. Actu-
ally we would have obtained the same results
using a cut-off value of 8 mm, because, in our
series, no endometrial carcinoma was observed
below the cut-off value of 10 mm. These values
are comparable to previous reports that showed a
high sensitivity of transvaginal ultrasonographic
measurement of endometrial thickness in exclud-
ing endometrial carcinoma, using cut-off values
of 4–5 mm (3, 4, 6, 9, 14, 15, 17). These reports
conclude that endometrial carcinoma is an un-
common finding among women with a thin endo-
metrium in transvaginal utrasonography (11, 15).
The use of transvaginal ultrasonographic mor-
phologic parameters to assess endometrial path-
ology reveals a lower sensitivity but higher speci-
ficity and increased negative predictive value for
malignant pathology.
Hysteroscopy gives evidence of a high diagnostic
accuracy, with sensitivity 97.7%, specificity 92%,
positive predictive value 95.5% and negative pre-
dictive value 95.8% for endometrial pathology, ac-
cording to previous reports (1, 6, 8, 10, 11, 13, 14).
Direct visualization of the uterine cavity is a simple
and effective method for investigating endometrial
and even endocervical pathologies (6). Hystero-
scopy showed great efficiency in the diagnosis of
focal abnormalities of the endometrium (4, 11),
which are hardly recognized by ultrasonography.
Hysteroscopy was also demonstrated to be of great
value to delineate an adequate therapeutic man-
agement for benign intracavitary pathology. How-
ever, it is a rather invasive procedure, so that, in
our study, among 15 women (17%), hysteroscopy
was impossible as an outpatient procedure, be-
cause of cervical stenosis.
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For assessment of endometrial carcinoma,
hysteroscopy revealed sensitivity of 88.9%, speci-
ficity of 98.3%, positive predictive value of 88.9%
and negative predictive value of 98.3%. There was
one endometrial carcinoma initially classified as
benign focal abnormality, but directed biopsy es-
tablished the correct diagnosis.
The combined use of ultrasonography and
hysteroscopy, associated with endometrial sam-
pling, did not miss any endometrial abnormality,
namely endometrial carcinoma.
In conclusion, our results showed that ultra-
sonography is an accurate method for detection of
endometrial pathology, and should be used as a
first line technique in the assessment of post-
menopausal bleeding. If the endometrial thickness
measured by transvaginal ultrasonography is Æ4
mm, there is no need to perform hysteroscopy and
biopsy, unless there are risk factors for endomet-
rial carcinoma or recurrent bleeding.
Hysteroscopy was a superior diagnostic pro-
cedure and should be performed whenever an
endometrial thickness is greater than 4 mm, or ill-
defined endometrial lining, recurrent bleeding or
risk factors for endometrial carcinoma are present.
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